Design, synthesis, in silico docking, and DFT analysis of 1,2,3–triazoles containing quinoxaline hybrids as effective antimicrobial agents
Abstract
It is crucial to create and find new, extremely powerful, broad–spectrum therapeutic medicines since the fast rise in multidrug-resistant microbial infections has become a significant worldwide concern. Because of its many biological activities, the heterocyclic framework has attracted a lot of attention. Click chemistry was used to create a novel series of quinoxaline–1,2,3–triazole derivatives using the Huisgen 1,3–dipolar cycloaddition between azide and terminal alkyne. The obtained compounds 4 ( a–k ) were isolated in moderate to good yields, and their structures were confirmed by HRMS, ¹H–NMR, ¹³C–NMR, and IR spectroscopic analyses, which clearly evidenced the formation of the acetamide–triazole ring and the expected substitution patterns. Among them, compounds 4c , 4e , 4 h , and 4j displayed the most potent inhibitory action against S. aureus , with zones of inhibition of 33 ± 1.67, 36 ± 0.93, 34 ± 1.20, and 35 ± 0.90 mm, respectively. After in vitro testing, compound 4e was identified as the most remarkable antitubercular compound, with an MIC of 2.76 ± 1.22 µ g. mL − 1 (Streptomycin had an MIC of 3.14 ± 0.55 µ g. mL − 1 ). Additionally, docking scores from molecular docking experiments demonstrate the potent compounds strong binding hydrophobic, H-bonding, and electrostatic interactions with their targets. Additionally, all of the compounds underwent ADME-Tox study to assess their pharmacokinetic characteristics, indicating that all of the compounds showed similar…
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.